FAR1

gene product
FLJ22728, MLSTD2, SDR10E1
The protein encoded by this gene is required for the reduction of fatty acids to fatty alcohols, a process that is required for the synthesis of monoesters and ether lipids. NADPH is required as a cofactor in this reaction, and 16-18 carbon saturated and unsaturated fatty acids are the preferred substrate. This is a peroxisomal membrane protein, and studies suggest that the N-terminus contains a large catalytic domain located on the outside of the peroxisome, while the C-terminus is exposed to the matrix of the peroxisome. Studies indicate that the regulation of this protein is dependent on plasmalogen levels. Mutations in this gene have been associated with individuals affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity (PMID: 25439727). A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jan 2015]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
40 antibodies from 15 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Novus Biologicals
2 antibodies
Atlas Antibodies
1 antibody
antibodies-online
10 antibodies
Invitrogen Antibodies
2 antibodies
Acris Antibodies GmbH
1 antibody
Abnova Corporation
1 antibody
LifeSpan BioSciences, Inc.
4 antibodies
Biorbyt
11 antibodies
Aviva Systems Biology
1 antibody
OriGene
1 antibody
Boster Biological Technology
1 antibody
ProSci
1 antibody
Sigma-Aldrich
2 antibodies
GeneTex
1 antibody
MyBioSource
1 antibody